Skip to main content
Binex Co., Ltd. logo

Binex Co., Ltd. — Investor Relations & Filings

Ticker · 053030 ISIN · KR7053030003 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2021-03-12 M&A Activity
Country KR South Korea
Listing KO 053030

About Binex Co., Ltd.

http://www.binex.co.kr/

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Recent filings

Filing Released Lang Actions
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Binex) announcing the acquisition of shares in another company (Noile-Immune Biotech Inc.). This type of disclosure, detailing the acquisition of equity in another entity, is a standard corporate action related to M&A or strategic investment activity. In the context of the provided categories, 'TAR' (M&A Activity) is the most appropriate classification for announcements regarding the acquisition of shares in other companies.
2021-03-12 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the regulatory authority. It contains the auditor's opinion (적정 - unqualified), key financial data (assets, liabilities, equity, profit/loss), and details regarding the accounting firm. While it provides financial highlights, it is a specific regulatory filing regarding the audit results rather than a full Annual Report (10-K) or a simple announcement of report publication (RPA). It fits the definition of an Audit Report/Information (AR) as it focuses on the audit opinion and financial statements. FY 2020
2021-03-12 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a correction (amendment) to a previously filed 'Change in Sales or Profit/Loss Structure' report. It details specific financial adjustments due to an external audit. Since it is a formal regulatory announcement of financial data changes rather than a full annual report or a simple publication notice, it falls under the general regulatory filing category. FY 2020
2021-03-12 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Notice of Annual General Meeting' (주주총회소집공고). It contains detailed financial statements (consolidated and separate balance sheets, income statements, cash flow statements) as part of the agenda items for the AGM. Since this is a formal regulatory filing providing updated materials for an upcoming shareholder meeting, it falls under the category of AGM-related materials.
2021-03-12 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Proxy Solicitation & Information Statement' (의결권대리행사권유참고서류). It details specific corrections made to the financial statements (consolidated and separate) due to ongoing audit processes. Since the primary purpose of this document is to provide updated proxy materials for a shareholder meeting, it falls under the Proxy Solicitation & Information Statement category.
2021-03-12 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for Binex Co., Ltd. It contains detailed corporate information, including company overview, capital changes, shareholding structure, and governance details. In the South Korean regulatory context, this is a standard 'Annual Report' (10-K equivalent) filed with the Financial Supervisory Service (FSS). FY 2020
2021-03-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.